Kuehn Law Encourages AGRX, SPR, ENV, and UMBF Investors to Contact Law Firm

Group 1 - Kuehn Law is investigating potential claims related to proposed mergers involving Agile Therapeutics, Spirit AeroSystems, and Envestnet to ensure shareholder value maximization and fair processes [1] - Agile Therapeutics will be acquired by Insud Pharma for $1.52 per share in cash [1] - Spirit AeroSystems will sell to Boeing Co. with shareholders receiving$37.25 per share in Boeing common stock [1] - Envestnet will merge with Bain Capital for $63.15 per share in cash [1] Group 2 - UMB Financial Corporation will acquire Heartland Financial USA Inc. in an all-stock deal valued at approximately$2.0 billion [2] - The merger is positioned as a significant event for shareholders, emphasizing the importance of their participation in maintaining market integrity [2] Group 3 - Kuehn Law encourages concerned shareholders to contact them for involvement in safeguarding shareholder interests, with no costs incurred by the investors [3] - Shareholders are advised to act promptly due to the time-sensitive nature of legal rights [3]